Ghent University Academic Bibliography

Journal Article
A1
open access

Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics

Pieter Vervaeke (UGent) , S.E. Borgos, Niek Sanders (UGent) and F. Combes

(2022) ADVANCED DRUG DELIVERY REVIEWS. 184.

Journal Article
A1
open access

Vaccinia virus protein B18R : influence on mRNA immunogenicity and translation upon non-viral delivery in different ocular cell types

An-Katrien Minnaert (UGent) , Joke Devoldere (UGent) , Karen Peynshaert (UGent) , Laure Vercruysse, Stefaan De Smedt (UGent) and Katrien Remaut (UGent)

(2021) PHARMACEUTICS. 13(1).

Add to list

Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers : a phase 1 trial

Cassandra Aldrich, Isabel Leroux-Roels (UGent) , Katell Bidet Huang, Mihai Alexandru Bica, Edde Loeliger, Oliver Schoenborn-Kellenberger, Lisa Walz, Geert Leroux-Roels (UGent) , Frank von Sonnenburg and Lidia Oostvogels

(2021) VACCINE. 39(8). p.1310-1318

Add to list

Journal Article
A1
open access

mRNA in cancer immunotherapy : beyond a source of antigen

Lien Van Hoecke (UGent) , Rein Verbeke (UGent) , Heleen Dewitte (UGent) , Ine Lentacker (UGent) , Karim Vermaelen (UGent) , Karine Breckpot and Sandra Van Lint (UGent)

(2021) MOLECULAR CANCER. 20(1).

Add to list

Journal Article
A1
open access

mRNA-lipid nanoparticle COVID-19 vaccines : structure and stability

Linde Schoenmaker, Dominik Witzigmann, Jayesh A. Kulkarni, Rein Verbeke (UGent) , Gideon Kersten, Wim Jiskoot and Daan J. A. Crommelin

(2021) INTERNATIONAL JOURNAL OF PHARMACEUTICS. 601.

Add to list

Journal Article
A1
open access

Physical transfection technologies for macrophages and dendritic cells in immunotherapy

Aranit Harizaj (UGent) , Stefaan De Smedt (UGent) , Ine Lentacker (UGent) and Kevin Braeckmans (UGent)

(2021) EXPERT OPINION ON DRUG DELIVERY. 18(2). p.229-247

Add to list

Journal Article
A1
open access

Macrophage reprogramming into a pro-healing phenotype by siRNA delivered with LBL assembled nanocomplexes for wound healing applications

Maryam Sharifiaghdam (UGent) , Elnaz Shaabani Sichani (UGent) , Zeynab Sharifiaghdam, Herlinde De Keersmaecker (UGent) , Bart Lucas (UGent) , Joris Lammens, Hossein Ghanbari, Ladan Teimoori-Toolabi, Chris Vervaet (UGent) , Thomas De Beer (UGent) , et al.

(2021) NANOSCALE. 13(36). p.15445-15463

Add to list

Journal Article
A1
open access

Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics : getting the message across

An-Katrien Minnaert (UGent) , Helena Vanluchene (UGent) , Rein Verbeke (UGent) , Ine Lentacker (UGent) , Stefaan De Smedt (UGent) , Koen Raemdonck (UGent) , Niek Sanders (UGent) and Katrien Remaut (UGent)

(2021) ADVANCED DRUG DELIVERY REVIEWS. 176.

Add to list

Journal Article
A1
open access

Intracellular delivery of mRNA in adherent and suspension cells by vapor nanobubble photoporation

Laurens Raes, Stephan Stremersch (UGent) , Juan Fraire (UGent) , Toon Brans (UGent) , Glenn Goetgeluk (UGent) , Stijn De Munter (UGent) , Lien Van Hoecke (UGent) , Rein Verbeke (UGent) , Jelter Van Hoeck, Ranhua Xiong (UGent) , et al.

(2020) NANO-MICRO LETTERS. 12(1).

Add to list

Journal Article
A1
open access

Influence of pathogenic stimuli on Müller cell transfection by lipoplexes

Karen Peynshaert (UGent) , Joke Devoldere (UGent) , Frederik Philips (UGent) , Fauve Vergauwe, Stefaan De Smedt (UGent) and Katrien Remaut (UGent)

(2020) EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. 150. p.87-95

Academic Bibliography

Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics

Vaccinia virus protein B18R : influence on mRNA immunogenicity and translation upon non-viral delivery in different ocular cell types

Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers : a phase 1 trial

mRNA in cancer immunotherapy : beyond a source of antigen

mRNA-lipid nanoparticle COVID-19 vaccines : structure and stability

Physical transfection technologies for macrophages and dendritic cells in immunotherapy

Macrophage reprogramming into a pro-healing phenotype by siRNA delivered with LBL assembled nanocomplexes for wound healing applications

Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics : getting the message across

Intracellular delivery of mRNA in adherent and suspension cells by vapor nanobubble photoporation

Influence of pathogenic stimuli on Müller cell transfection by lipoplexes

Contents

Support

Contact